Catalyst Wire Dossier Catalyst Wire Dossier

EffiCacy, Safety and ToLErability of a Novel Ocular ANtiseptic for Ocular Use (CLEAN)

· iRenix Medical, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EffiCacy, Safety and ToLErability of a Novel Ocular ANtiseptic for Ocular Use (CLEAN), covering 2022-05-24 to 2022-05-24. Get the full timeline:

Most recent: Clinical Trial Update: EffiCacy, Safety and ToLErability of a Novel Ocular ANtiseptic for Ocular Use (CLEAN) [Phase 3]

See pricing